Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Alzheimer Disease × Telemedicine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 6 Colorectal Neoplasms 4 Lung Neoplasms 3 Breast Neoplasms 3 Uterine Cervical Neoplasms 2 Prostatic Neoplasms 2 Pain 2 Motor Activity 2 Carcinoma, Non-Small-Cell Lung 2 Breast Carcinoma In Situ 2 Squamous Cell Carcinoma of Head and Neck 1 Smoking Cessation 1 Sedentary Behavior 1 Sarcoma 1 Recurrence 1 Pulmonary Disease, Chronic Obstructive 1 Polyps 1 Papillomavirus Infections 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Metastatic Pancreatic Adenocarcinoma 1 Malignant Hepatobiliary Neoplasm 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Acute 1 Hodgkin Disease 1 Hereditary Breast and Ovarian Cancer Syndrome 1 Hematopoietic and Lymphatic System Neoplasm 1 Head and Neck Neoplasms 1 FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1

Interventions

Dexamethasone 3 XENP 1595 2 Electroencephalography 2 pomalidomide 1 ixazomib 1 birtamimab 1 UE2343 1 Telemedicine 1 Tablets 1 Standard of Care 1 Rosiglitazone 1 Propofol 1 Positron-Emission Tomography 1 Methods 1 Melphalan 1 Mass Screening 1 Magnetic Resonance Imaging 1 Lysine Acetyltransferase 5 1 Hypnosis 1 Hormones 1 Exercise 1 Ethanol 1 Donepezil 1 Cyclophosphamide 1 Control Groups 1 Calcium Dobesilate 1 Bortezomib 1 Blood Specimen Collection 1 Amyloid 1 7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07332377 2026-03-18

PsyMINT

Virginia Commonwealth University

Phase NA Recruiting

Agnosia, Alzheimer Disease, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡